Real World Safety of CT-P10 (Anti-Cd 20 Monoclonal Antibodies Biosimilar) in Rheumatic and Autoimmune Diseases.

Wanruchada Katchamart,Pintip Ngamjanyaporn, Annop Orawongpaisarn, Thossapoom Phubangkertphon,Sasimon Borrirukwisitsak, Nichapa Dechapaphapitak

BMC Rheumatology（2022）

引用 0|浏览4

暂无评分

关键词

Rituximab,CT-P10,Biosimilar anti-CD 20 antibodies,Adverse event,Infusion reaction

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要